Pesquisas alternativas:
after armed » after ahmed (Expandir a Pesquisa), after armeo (Expandir a Pesquisa), after arm (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
phase re » phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa), phase rop (Expandir a Pesquisa)
after armed » after ahmed (Expandir a Pesquisa), after armeo (Expandir a Pesquisa), after arm (Expandir a Pesquisa)
phase rate » phase route (Expandir a Pesquisa), phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa)
phase re » phase rule (Expandir a Pesquisa), phase role (Expandir a Pesquisa), phase rop (Expandir a Pesquisa)
321
“...AIMS: The study objective was to investigate the safety and tolerability of up-titration to high...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
322
Por Lombardi, G, de Salvo, G, Rudà, R, Franceschi, E, Eoli, M, Faedi, M, Pace, A, Lolli, I, Rizzato, S, Germano, D, Pasqualetti, F, Farina, M, Magni, G, Bellu, L, Caccese, M, Pambuku, A, Bergo, E, Indraccolo, S, Gardiman, M, Soffietti, R, Zagonel, V
Publicado no Neuro Oncol (2018)
“...). Secondary objectives were PFS, disease control rate (DCR), safety, quality of life (QoL); exploratory...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
323
Por Nakamura, Masato, Aoyama, Toru, Ishibashi, Keiichiro, Tsuji, Akihito, Takinishi, Yasutaka, Shindo, Yoshiaki, Sakamoto, Junichi, Oba, Koji, Mishima, Hideyuki
Publicado no Cancer Chemother Pharmacol (2016)
“... group. Crude disease control rates were 55.6% in the Cet group and 47.4% in the CetI group. After a...”Publicado no Cancer Chemother Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
324
Por Aghajanian, Carol, Blank, Stephanie V., Goff, Barbara A., Judson, Patricia L., Teneriello, Michael G., Husain, Amreen, Sovak, Mika A., Yi, Jing, Nycum, Lawrence R.
Publicado em 2012
“... survival, and safety. RESULTS: Overall, 484 patients were randomly assigned. PFS for the BV arm...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
325
Por Kong, Xiao-Tang, Lai, Albert, Carrillo, Jose A, Fu, Dan Beverly, Meyskens, Frank, Bota, Daniela A
Publicado no Neuro Oncol (2018)
“... to the combination therapy or the standard therapy arm. Safety will be assessed by CTCAE V4.03. We will use Kaplan...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
326
Por Morris, Georgina C., Wiggins, Rebecca C., Woodhall, Sarah C., Bland, J. Martin, Taylor, Carol R., Jespers, Vicky, Vcelar, Brigitta A., Lacey, Charles J.
Publicado no PLoS One (2014)
“... in vaginal secretions has not been studied. OBJECTIVES: To assess the pharmacokinetics and safety of the mAbs...”Publicado no PLoS One (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
327
Por Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I
Publicado no Br J Cancer (2017)
“...) or at 3 months (LG strata), objective response rate (ORR), and safety. RESULTS: A total of 40 patients...”Publicado no Br J Cancer (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
328
Por Cornblath, David R., Hartung, Hans‐Peter, Katzberg, Hans D., Merkies, Ingemar S. J., van Doorn, Pieter A.
Publicado no J Peripher Nerv Syst (2018)
“... of response to intravenous immunoglobulin (IVIg) therapy. This randomised phase III study in patients...”Publicado no J Peripher Nerv Syst (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
329
Por Kesari, Santosh, Juarez, Tiffany, Carrillo, Jose, Truong, Judy, Nguyen, Minhdan, Heng, Annie, Gill, Jaya, Nguyen, Hanh, Nomura, Natsuko, Grigorian, Berta, Hou, Shihe, Schmid, Anita, Desai, Neil
Publicado no Neuro Oncol (2019)
“.... The goal of this prospective, multi-cohort open-label phase 2 study is to evaluate the efficacy and safety...”Publicado no Neuro Oncol (2019)
Obter o texto integral
Obter o texto integral
Artigo
330
Por Lim, Sung Hee, Shim, Young Mog, Park, Se Hoon, Kim, Hong Kwan, Choi, Young Soo, Ahn, Myung-Ju, Park, Keunchil, Zo, Jae Ill, Sun, Jong-Mu
Publicado no Cancer Res Treat (2017)
“... (ESCC) remains controversial. We evaluated the efficacy and safety of leucovorin and 5-fluorouracil (LV5...”Publicado no Cancer Res Treat (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
331
Por Juric, Dejan, Janku, Filip, Rodón, Jordi, Burris, Howard A., Mayer, Ingrid A., Schuler, Martin, Seggewiss-Bernhardt, Ruth, Gil-Martin, Marta, Middleton, Mark R., Baselga, José, Bootle, Douglas, Demanse, David, Blumenstein, Lars, Schumacher, Karl, Huang, Alan, Quadt, Cornelia, Rugo, Hope S.
Publicado no JAMA Oncol (2018)
“...-label, single-arm, phase 1b study of alpelisib plus fulvestrant was conducted at 10 centers in 5...”Publicado no JAMA Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
332
Por Di Bartolomeo, Maria, Niger, Monica, Morano, Federica, Corallo, Salvatore, Antista, Maria, Tamberi, Stefano, Lonardi, Sara, Di Donato, Samantha, Berardi, Rossana, Scartozzi, Mario, Cardellino, Giovanni Gerardo, Di Costanzo, Francesco, Rimassa, Lorenza, Luporini, Alberto Gianluigi, Longarini, Raffaella, Zaniboni, Alberto, Bertolini, Alessandro, Tomasello, Gianluca, Pinotti, Graziella, Scagliotti, Giorgio, Tortora, Giampaolo, Bonetti, Andrea, Spallanzani, Andrea, Frassineti, Giovanni Luca, Tassinari, Davide, Giuliani, Francesco, Cinieri, Saverio, Maiello, Evaristo, Verusio, Claudio, Bracarda, Sergio, Catalano, Vincenzo, Basso, Michele, Ciuffreda, Libero, De Vita, Ferdinando, Parra, Hector Soto, Fornaro, Lorenzo, Caporale, Marta, de Braud, Filippo, Pietrantonio, Filippo
Publicado no BMC Cancer (2019)
“... according to arm treatment, safety, quality of life. Exploratory studies including Next-Generation...”Publicado no BMC Cancer (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
333
Por Yardley, Denise A., Hart, Lowell, Bosserman, Linda, Salleh, Mansoor N., Waterhouse, David M., Hagan, Maura K., Richards, Paul, DeSilvio, Michelle L., Mahoney, Janine M., Nagarwala, Yasir
Publicado em 2012
“... within 6 months of adjuvant chemotherapy. This was an open-label, single-arm, multicenter, Phase II study...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
334
Por Hayne, Dickon, Stockler, Martin, McCombie, Steve P., Chalasani, Venu, Long, Anne, Martin, Andrew, Sengupta, Shomik, Davis, Ian D.
Publicado no BMC Cancer (2015)
“... multi-centre phase III trial comparing the efficacy and safety of standard intravesical therapy (BCG...”Publicado no BMC Cancer (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
335
Por MOUNTZIOS, GIANNIS, ARAVANTINOS, GERASIMOS, ALEXOPOULOU, ZOI, TIMOTHEADOU, ELENI, MATSIAKOU, FOTINI, CHRISTODOULOU, CHRISTOS, LASCHOS, KONSTANTINOS, GALANI, ELENI, KOUTRAS, ANGELOS, BAFALOUKOS, DIMITRIOS, LINARDOU, HELENA, PECTASIDES, DIMITRIOS, VARTHALITIS, IOANNIS, PAPAKOSTAS, PAVLOS, KALOFONOS, HARALAMBOS P., FOUNTZILAS, GEORGE
Publicado no Mol Clin Oncol (2016)
“..., randomized phase III trial of prophylactic vs. hemoglobin (Hb)-based (threshold: 11 mg/dl) ESA administration...”Publicado no Mol Clin Oncol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
336
Por Green, Angela K., Corty, Robert W., Wood, William A., Meeneghan, Mathew, Reeder-Hayes, Katherine E., Basch, Ethan, Milowsky, Matthew I., Dusetzina, Stacie B.
Publicado no Oncologist (2015)
“... with mitoxantrone and prednisone. PATIENTS AND METHODS. Control arm data from two phase III randomized control...”Publicado no Oncologist (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
337
Por Nam, Byung Ho, Kim, Young-Woo, Reim, Daniel, Eom, Bang Wool, Yu, Wan Sik, Park, Young Kyu, Ryu, Keun Won, Lee, Young Joon, Yoon, Hong Man, Lee, Jun Ho, Jeong, Oh, Jeong, Sang Ho, Lee, Sang Eok, Lee, Sang Ho, Yoon, Ki Young, Seo, Kyung Won, Chung, Ho Young, Kwon, Oh Kyoung, Kim, Tae Bong, Lee, Woon Ki, Park, Seong Heum, Sul, Ji-Young, Yang, Dae Hyun, Lee, Jong Seok
Publicado em 2013
“... arm. The primary endpoint is the non-compliance rate of D2 dissection; relevant secondary endpoints...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
338
Por Taal, Walter, Enting, Roelien, Taphoorn, Martin, Smits, Marion, Dubbink, Hendrikus, Beerepoot, Laurens, Hanse, Monique, Bralten, Linda, Oosterkamp, Hendrika, Walenkamp, Annemiek, Buter, Jan, Honkoop, Aafke, Boerman, Dolf, de Vos, Filip, Bromberg, Jacoline, Vernhout, Rene, van der Holt, Bronno, van den Bent, Martin
Publicado em 2014
“... preplanned safety review after the first 8 patients the lomustine dose in the combination arm was reduced...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Artigo
339
A phase I/II dose-escalation study investigating all-oral ixazomib-melphalan-prednisone induction...
Por San-Miguel, Jesús F., Echeveste Gutierrez, Maria-Asunción, Špicka, Ivan, Mateos, María-Victoria, Song, Kevin, Craig, Michael D., Bladé, Joan, Hájek, Roman, Chen, Christine, Di Bacco, Alessandra, Estevam, Jose, Gupta, Neeraj, Byrne, Catriona, Lu, Vickie, van de Velde, Helgi, Lonial, Sagar
Publicado no Haematologica (2018)
“... the complete plus very good partial response rate. In phase I, patients were enrolled to 4 arms investigating...”Publicado no Haematologica (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
340
Por Tobias Winkler, Matthew L. Costa, Racheli Ofir, Ornella Parolini, Sven Geissler, Hans-Dieter Volk, Christian Eder
Publicado em 2022-04-01
“...-energy femoral neck fractures (FNF) will be allocated to two arms and receive an intramuscular injection...”Publicado em 2022-04-01
Obter o texto integral
Artigo